Item 7.01 Regulation FD Disclosure.

Rani Therapeutics Holdings, Inc. (the "Company") is furnishing a copy of an investor presentation (the "Presentation") that the Company intends to use, in whole or in part, during the Company's presentation at the 2021 Cantor Fitzgerald Virtual Global Healthcare Conference on September 30, 2021. The Presentation, including the video content contained therein, can be accessed through the "Investors" section of the Company's website. A copy of the Presentation is furnished as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated by reference herein.

All of the information furnished in this Item 7.01 and Item 9.01 (including Exhibit 99.1) shall not be deemed to be "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended ("Exchange Act"), and shall not be incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.

Item 9.01 Financial Statements and Exhibits.




(d) Exhibits



Exhibit
Number       Exhibit Description

99.1           Rani Therapeutics Holdings, Inc. Corporate Presentation dated
             September 2021.

104          Cover Page Interactive Data File (embedded within the Inline XBRL
             document)

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses